Related references
Note: Only part of the references are listed.Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical
Chao Tang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Necroptotic virotherapy of oncolytic alphavirus M1 cooperated with Doxorubicin displays promising therapeutic efficacy in TNBC
Jiayu Zhang et al.
ONCOGENE (2021)
Enterovirus A71 Oncolysis of Malignant Gliomas
Xiaowei Zhang et al.
MOLECULAR THERAPY (2020)
Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients
O. Molinier et al.
RESPIRATORY MEDICINE AND RESEARCH (2020)
Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis
Melanie Fritsch et al.
NATURE (2019)
Overcoming resistance to anti-PD immunotherapy in a syngeneic mouse lung cancer model using locoregional virotherapy
Xiang Yan et al.
ONCOIMMUNOLOGY (2018)
Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus
Nicola E. Annels et al.
MOLECULAR THERAPY-ONCOLYTICS (2018)
A Novel Combination Therapy for Human Oxaliplatin-resistant Colorectal Cancer Using Oxaliplatin and Coxsackievirus A11
Beibei Wang et al.
ANTICANCER RESEARCH (2018)
MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation
Praveen K. Bommareddy et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
A neonatal mouse model of central nervous system infections caused by Coxsackievirus B5
Qunying Mao et al.
EMERGING MICROBES & INFECTIONS (2018)
Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner
Stephanie A. Conos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Employing RNA viruses to fight cancer: novel insights into oncolytic virotherapy
Doerthe Masemann et al.
BIOLOGICAL CHEMISTRY (2017)
EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases
Qunying Mao et al.
EMERGING MICROBES & INFECTIONS (2016)
Coxsackievirus A16 Infection Induces Neural Cell and Non-Neural Cell Apoptosis In Vitro
Zhaolong Li et al.
PLOS ONE (2014)
RNA Virus Reverse Genetics and Vaccine Design
Christopher C. Stobart et al.
VIRUSES-BASEL (2014)
Applications of coxsackievirus A21 in oncology
Stephen Bradley et al.
ONCOLYTIC VIROTHERAPY (2014)
Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma
Shohei Miyamoto et al.
CANCER RESEARCH (2012)
Enhanced Antitumor Effects of an Engineered Measles Virus Edmonston Strain Expressing the Wild-type N, P, L Genes on Human Renal Cell Carcinoma
Xin Meng et al.
MOLECULAR THERAPY (2010)
Immunogenic death of colon cancer cells treated with oxaliplatin
A. Tesniere et al.
ONCOGENE (2010)
Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
Robin J. Prestwich et al.
CLINICAL CANCER RESEARCH (2008)
Engineering microRNA responsiveness to decrease virus pathogenicity
Elizabeth J. Kelly et al.
NATURE MEDICINE (2008)
ICAM-1 expression determines malignant potential of cancer
Christina L. Roland et al.
SURGERY (2007)
Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus
Rosa Maria Diaz et al.
CANCER RESEARCH (2007)
Share Paper
